BioCardia, Inc. Warrant
BCDAW
BCDAW was delisted on the 2nd of August, 2024.
5 hedge funds and large institutions have $1.22K invested in BioCardia, Inc. Warrant in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
96% less capital invested
Capital invested by funds: $29.6K → $1.22K (-$28.4K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.67K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.87K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$70 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $574 | -$70 | -797 | -2% |
|
2
Osaic Holdings
Scottsdale,
Arizona
| $382 | – | – | – |
|
|
G
3
GenTrust
Miami,
Florida
| $191 | – | – | – |
|
4
Bank of America
Charlotte,
North Carolina
| $69 | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$1.87K | -21,206 | -100% |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$2.67K | -14,287 | Closed |
|
BCDAW Hedge Fund Activity: Q4 2023 in Review
5 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q4 2023, worth a combined $1.22K — down 96% from $29.6K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BCDAW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $2.67K sold.
- 5 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q4 2023, down from 6 in Q3 2023.
- Funds reported $1.22K of BioCardia, Inc. Warrant stock for Q4 2023, down 96% quarter-over-quarter.
- 0 funds opened new BioCardia, Inc. Warrant positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest BioCardia, Inc. Warrant seller in Q4 2023 was Susquehanna International Group, an estimated $2.67K sold.
Based on aggregated 13F filings for Q4 2023.